MIR News and Press, Mirion Technologies Inc. Class A From 04/13/24

2024-04-13 05:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...

HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this...

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024. About Mirion Mirion (NYSE: MIR) is a global leader in radiat...

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe. The event will begin at 9:00 AM ET on Monday, February 26, 2024 and will feature an online portal for investors to submit...

2024-02-14 12:40:19 ET Mirion Technologies, Inc. (MIR) Q4 2023 Earnings Conference Call February 14, 2024, 10:00 AM ET Company Participants Alex Gaddy - Senior Vice President of Strategy, Investor Relations and Treasurer Thomas Logan - Chief Executive Officer Bri...

2024-02-13 16:56:46 ET More on Mirion Technologies Mirion Technologies: A Good Way To Diversify Uranium Sector Exposure Seeking Alpha’s Quant Rating on Mirion Technologies Historical earnings data for Mirion Technologies Financial information for Mirio...

Revenues for the fourth quarter increased 5.7% to $230.4 million, compared to $217.9 million in the same period last year. Net loss was $15.2 million in the fourth quarter, compared to a net loss of $153.4 million in the same period last year, a 90.1% improvement. Adjusted EBITDA was ...

ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...

2024-02-12 17:35:52 ET More on Mirion Technologies Mirion Technologies: A Good Way To Diversify Uranium Sector Exposure Seeking Alpha’s Quant Rating on Mirion Technologies Historical earnings data for Mirion Technologies Financial information for Mirio...